Gaviscon and gastroesophageal reflux in children.
Buts
J P
JP
Leclercq
V
V
D000464:Alginates / Q000627:therapeutic use*; D000536:Aluminum Hydroxide / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000628:therapy*; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D011897:Random Allocation; D012824:Silicic Acid / Q000627:therapeutic use*; D012822:Silicon Dioxide / Q000627:therapeutic use*; D017693:Sodium Bicarbonate
D000464:Alginates; D001639:Bicarbonates; D004338:Drug Combinations; D012824:Silicic Acid; D000536:Aluminum Hydroxide; C007829:alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination; D012822:Silicon Dioxide; D017693:Sodium Bicarbonate; D008787:Metoclopramide